Author:
Zent Clive S.,Kay Neil E.
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Zent CS, Kyasa MJ, Evans R, Schichman SA: Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer 2001, 92:1325–1330.
2. Muller-Hermelink HK, Catovsky D, Montserrat E, Harris NL: Chronic lymphocytic leukemia/small lymphocytic lymphoma. In Tumours of Haematopoietic and Lymphoid Tissues. Edited by Jaffe E, Harris N, Stein H, Vardiman J. Lyon, France: IARC Press; 2001:127–130. Definitive description and diagnostic criteria for CLL.
3. Dighiero G, Binet J-L: When and how to treat chronic lymphocytic leukemia. N Engl J Med 2000, 343:1799–1801.
4. Guarini A, Gaidano G, Mauro FR, et al.: Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood 2003, 102:1035–1041.
5. Byrd JC, Murphy T, Howard RS, et al.: Rituximab using a thrice weekly dosing schedule in B-cell lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity. J Clin Oncol 2001, 19:2153–2164.